Navigation Links
Wyeth Receives Approvable Letter from FDA for Bazedoxifene for the Prevention of Postmenopausal Osteoporosis
Date:12/24/2007

ducts (including that there can be no assurance that our pending NDAs for bazedoxifene will be approved or that the product will ever be successfully commercialized); government cost-containment initiatives; restrictions on third-party payments for our products; substantial competition in our industry, including from branded and generic products; data generated on our products; the importance of strong performance from our principal products and our anticipated new product introductions; the highly regulated nature of our business; product liability, intellectual property and other litigation risks and environmental liabilities; uncertainty regarding our intellectual property rights and those of others; difficulties associated with, and regulatory compliance with respect to, manufacturing of our products; risks associated with our strategic relationships; economic conditions including interest and currency exchange rate fluctuations; changes in generally accepted accounting principles; trade buying patterns; the impact of legislation and regulatory compliance; risks and uncertainties associated with global operations and sales; and other risks and uncertainties, including those detailed from time to time in our periodic reports filed with the Securities and Exchange Commission, including our current reports on Form 8-K, quarterly reports on Form 10-Q and annual report on Form 10-K, particularly the discussion under the caption "Item 1A, Risk Factors." The forward-looking statements in this press release are qualified by these risk factors. We assume no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise.


'/>"/>
SOURCE Wyeth Pharmaceuticals
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Wyeth and Nycomed Announce Court Denial of Preliminary Injunction
2. Wyeths Pearl River, N.Y. Facility Celebrates 100 Years of Achievements in Health care
3. Wyeth Announces Election of Bernard Poussot as CEO of Company Effective January 1, 2008
4. Wyeth Announces the Election of Robert M. Amen to Its Board of Directors
5. Wyeth Comments on PREVNAR and Trends in Pneumococcal Disease
6. Wyeth to Appeal Nevada Hormone Therapy Trial Verdict
7. Wyeth Reports Earnings Results for the 2007 Third Quarter and First Nine Months
8. Wyeth Consumer Healthcare Initiates Voluntary Recall and Replacement Program for Several Robitussin Products and Childrens Dimetapp Cold & Chest Congestion
9. Wyeth Consumer Healthcare Announces the Availability of Centrum Cardio and New Formula Centrum Products
10. Wyeth to Present at the Credit Suisse First Boston Healthcare Conference
11. Wyeth Receives FDA Approval of Protonix for Delayed-Release Oral Suspension
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2008)...eading Content Rights Management System, Supports... Content Spend, WEST CHESTER, Pa., Oct. 13 /PRNew...ding global pharmaceutical manufacturer has integr...primary platform for the,secure distribution, data...cs for their new product video content. Imperium i...
(Date:10/13/2008)...swire/ -- The National Coalition for,Quality Color...ncerns over,the National CT Colonography Study pub...Medicine. The evidence must be closely evaluated, ...y is not without significant,potential risks. The ...py,remains the "Gold Standard" for colorectal canc...
(Date:10/13/2008)...blem in daily life, survey shows, PORTLAND, Ore.,...three-quarters of people living with psoriasis say...e, according to a National Psoriasis,Foundation 20...viduals with psoriasis and psoriatic arthritis,als...ly lives, shapes their,feelings about themselves a...
(Date:10/13/2008)...swire/ -- During the Pri-Med New York,conference a...are providers,took a 20-question quiz prepared by ...n Somerset, NJ. The quiz tested basic knowledge of..., EMR software, and healthcare,administration., T... The average number,of correct answers was only 7....
Breaking Medicine News(10 mins):Health News:Global Pharma Integrates Imperium(TM) to Support Launch Content ROI Initiatives! 2Health News:National Coalition for Quality Colorectal Cancer Screening and Care Conveys Concerns over CT Colonography 2Health News:National Coalition for Quality Colorectal Cancer Screening and Care Conveys Concerns over CT Colonography 3Health News:National Psoriasis Foundation Releases 2008 Study Results 2Health News:MTBC Practice Management Quiz Sends Message to Doctors: There is Real Room for Improvement or a Need to Outsource 2
...ia Medical School presented their study that shows...tic neuropathy, or nerve damage.Topiramate (Topama...t research shows it can also promote significant w...2 diabetes, the drug showed evidence of improving ...
...p the hearts of children with diabetes. Researcher...indings over the weekend at the American Diabetes ...ding to the American Diabetes Association, people ...likely to have heart disease as compared to those ...
...s to numerous health concerns. But a new study fin...ink weight to athletic performance and appearance ...s also fail to see the importance of a healthy wei...n children more in terms of appearance and self-es...
... can have a serious impact on their health and qua... Educators (AADE) says about a third of the estima...sis, the most common type of nail fungus. Because ...ced ability to fight infection, people with diabet...
Other Medicine News:
(Date:10/9/2008)... World Sight Day 2008 focuses on the need to ...ct. 9 /- Of the 45 million people wor...and three-quarters of them could,have avoided thei...,treated., To view the Multimedia News Release, g..., Alcon, the world,s leader in eye care products ...
(Date:10/9/2008)... Top Line Clinical Results Expected in Novemb...Call/ -- SCOLR Pharma, Inc.,(Amex: DDD ) announce...osing,for the third of its three pivotal trials to...on of 12-hour extended-release (ER) ibuprofen for,...ects to report top-line,results from this pivotal ...
(Date:10/9/2008)... STOCKHOLM, October 9 /PRNewswire-FirstCall/ ...fluential medical journal, the New England Journal...s from the company,s study,of the Diamyd(R) diabet...ww.newscom.com/cgi-bin/prnh/20080314/297194 ), T...ite,( http://www.nejm.org ) and will be in print o...
(Date:10/8/2008)... Acceptance Will Reduce Animal Use in Cosmeti.../- MatTek Corp. today announced,that ...lti-laboratory,"catch-up" validation study on MatT.... The test results demonstrated the required sensi...as a validated alternative to animal,testing for d...
Breaking Medicine Technology:ORBIS and Alcon Call Attention to the Aging Eye 2ORBIS and Alcon Call Attention to the Aging Eye 3SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 3Diamyd(R) Study Published in Prestigious New England Journal of Medicine 2Diamyd(R) Study Published in Prestigious New England Journal of Medicine 3Diamyd(R) Study Published in Prestigious New England Journal of Medicine 4MatTek's EpiDerm In Vitro Tissues Headed for Validation in Europe 2Reclast 28R 29 Receives US FDA Approval as First and Only Once Yearly Treatment for Women With Postmenopausal Osteoporosis 1 1Reclast 28R 29 Receives US FDA Approval as First and Only Once Yearly Treatment for Women With Postmenopausal Osteoporosis 1 2Reclast 28R 29 Receives US FDA Approval as First and Only Once Yearly Treatment for Women With Postmenopausal Osteoporosis 1 3Reclast 28R 29 Receives US FDA Approval as First and Only Once Yearly Treatment for Women With Postmenopausal Osteoporosis 1 4Reclast 28R 29 Receives US FDA Approval as First and Only Once Yearly Treatment for Women With Postmenopausal Osteoporosis 1 5Reclast 28R 29 Receives US FDA Approval as First and Only Once Yearly Treatment for Women With Postmenopausal Osteoporosis 1 6Muscle mass 3A Scientists identify novel mode of transcriptional regulation during myogenesis 92 1A new radiation therapy treatment developed for head and neck cancer patients 87 1A new radiation therapy treatment developed for head and neck cancer patients 87 2Scientists retrace evolution with first atomic structure of an ancient protein 82 1Scientists retrace evolution with first atomic structure of an ancient protein 82 2Scientists retrace evolution with first atomic structure of an ancient protein 82 3
...ALISO VIEJO, Calif.--(BUSINESS WIRE)--May 1, 2007 ...nced that data on the,long-term safety of the inve...inidine) and the prevalence of Involuntary,Emotion... during a,poster session at the American Academy o...he information was presented in the,following post...
...Drugs Might Increase Risk of Tumor Growth, Data Su...- Echoing recent FDA,warnings, a research group fr...ve use of a group of drugs called,"erythropoiesis-...,cancer patients, according to a commentary in the...Med Press. , The article by Dr. Terence R. Lappin ...
Other Medicine Technology:Avanir Pharmaceuticals Presents IEED Prevalence and Updated Zenvia,Long-Term Safety Data at AAN Annual Meeting 2Avanir Pharmaceuticals Presents IEED Prevalence and Updated Zenvia,Long-Term Safety Data at AAN Annual Meeting 3Avanir Pharmaceuticals Presents IEED Prevalence and Updated Zenvia,Long-Term Safety Data at AAN Annual Meeting 4Avanir Pharmaceuticals Presents IEED Prevalence and Updated Zenvia,Long-Term Safety Data at AAN Annual Meeting 5Researchers Urge Caution in Using ESAs for Cancer-Related Anemia 2Researchers Urge Caution in Using ESAs for Cancer-Related Anemia 3
...the rapid, detection of platelet dysfunction. It i... that uniquely simulates the in vivo function of p...s platelet function under high shear conditions si...lood vessel. Testing is performed using a small wh...
...rming erythrocyte sedimentation rate (ESR) tests u...es-matic System DIESSE brings to the clinical diag... which addresses and resolves every technical limi...e.,By means of a fully automated analyzer and a es...
...n rate analysers, which are especially user-friend...stablished advantages of the existing analysers wi...rantee time-saving standardised analysis of the er...s an essential aspect of daily recurrent routine a...
Blood sedimentation rate analysis
Medicine Products: